Terms: = Bone cancer AND MECOM, MDS1-EVI1, EVI1, 2122, ENSG00000085276, Q03112, PRDM3
73 results:
1. Classical cannabinoid receptors as target in cancer-induced bone pain: a systematic review, meta-analysis and bioinformatics validation.
Zeng F; Wade A; Harbert K; Patel S; Holley JS; Dehghanpuor CK; Hopwood T; Marino S; Sophocleous A; Idris AI
Sci Rep; 2024 Mar; 14(1):5782. PubMed ID: 38461339
[TBL] [Abstract] [Full Text] [Related]
2. Efficacy of novel agents against cellular models of familial platelet disorder with myeloid malignancy (FPD-MM).
Mill CP; Fiskus WC; DiNardo CD; Reville P; Davis JA; Birdwell CE; Das K; Hou H; Takahashi K; Flores L; Ruan X; Su X; Loghavi S; Khoury JD; Bhalla KN
Blood Cancer J; 2024 Feb; 14(1):25. PubMed ID: 38316746
[TBL] [Abstract] [Full Text] [Related]
3. The prognostic role of neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio, and systemic immune-inflammation index on short- and long-term outcome following surgery for spinal metastases.
Ryvlin J; Kim SW; Hamad MK; Fourman MS; Eleswarapu A; Murthy SG; Gelfand Y; De la Garza Ramos R; Yassari R
J Neurosurg Spine; 2024 Apr; 40(4):475-484. PubMed ID: 38157531
[TBL] [Abstract] [Full Text] [Related]
4. mecom Deficiency: from bone Marrow Failure to Impaired B-Cell Development.
Voit RA; Sankaran VG
J Clin Immunol; 2023 Aug; 43(6):1052-1066. PubMed ID: 37407873
[TBL] [Abstract] [Full Text] [Related]
5. Expanded phenotypic and hematologic abnormalities beyond bone marrow failure in mecom-associated syndromes.
Lozano Chinga MM; Bertuch AA; Afify Z; Dollerschell K; Hsu JI; John TD; Rao ES; Rowe RG; Sankaran VG; Shimamura A; Williams DA; Nakano TA
Am J Med Genet A; 2023 Jul; 191(7):1826-1835. PubMed ID: 37067177
[TBL] [Abstract] [Full Text] [Related]
6. Clinical significance of EVI-1 gene expression and aberrations in patient with de-novo acute myeloid and acute lymphoid leukemia.
Nabil R; Abdellateif MS; Gamal H; Hassan NM; Badawy RH; Ghareeb M; El Ashry MS
Leuk Res; 2023 Mar; 126():107019. PubMed ID: 36657369
[TBL] [Abstract] [Full Text] [Related]
7. Reduced-intensity conditioning is effective for allogeneic hematopoietic stem cell transplantation in infants with mecom-associated syndrome.
Irie M; Niihori T; Nakano T; Suzuki T; Katayama S; Moriya K; Niizuma H; Suzuki N; Saito-Nanjo Y; Onuma M; Rikiishi T; Sato A; Hangai M; Hiwatari M; Ikeda J; Tanoshima R; Shiba N; Yuza Y; Yamamoto N; Hashii Y; Kato M; Takita J; Maeda M; Aoki Y; Imaizumi M; Sasahara Y
Int J Hematol; 2023 Apr; 117(4):598-606. PubMed ID: 36515795
[TBL] [Abstract] [Full Text] [Related]
8. Aberrant evi1 splicing contributes to evi1-rearranged leukemia.
Tanaka A; Nakano TA; Nomura M; Yamazaki H; Bewersdorf JP; Mulet-Lazaro R; Hogg S; Liu B; Penson A; Yokoyama A; Zang W; Havermans M; Koizumi M; Hayashi Y; Cho H; Kanai A; Lee SC; Xiao M; Koike Y; Zhang Y; Fukumoto M; Aoyama Y; Konuma T; Kunimoto H; Inaba T; Nakajima H; Honda H; Kawamoto H; Delwel R; Abdel-Wahab O; Inoue D
Blood; 2022 Aug; 140(8):875-888. PubMed ID: 35709354
[TBL] [Abstract] [Full Text] [Related]
9. 3q26 Amplifications in Cervical Squamous Carcinomas.
Voutsadakis IA
Curr Oncol; 2021 Jul; 28(4):2868-2880. PubMed ID: 34436017
[TBL] [Abstract] [Full Text] [Related]
10. Pubectomy and urinary reconstruction provides definitive treatment of urosymphyseal fistula following prostate cancer treatment.
Andrews JR; Hebert KJ; Boswell TC; Avant RA; Boonipatt T; Kreutz-Rodrigues L; Bakri K; Houdek MT; Karnes RJ; Viers BR
BJU Int; 2021 Oct; 128(4):460-467. PubMed ID: 33403768
[TBL] [Abstract] [Full Text] [Related]
11. Targeted RNA-Sequencing Enables Detection of Relevant Translocations and Single Nucleotide Variants and Provides a Method for Classification of Hematological Malignancies-RANKING.
de Lange K; de Boer EN; Bosga A; Alimohamed MZ; Johansson LF; Mulder AB; Vellenga E; van Diemen CC; Deelen P; van den Berg E; Sikkema-Raddatz B
Clin Chem; 2020 Dec; 66(12):1521-1530. PubMed ID: 33257979
[TBL] [Abstract] [Full Text] [Related]
12. Secondary acquisition of BCR-ABL1 fusion in de novo GATA2-mecom positive acute myeloid leukemia with subsequent emergence of a rare KMT2A-ASXL2 fusion.
Blackburn PR; Huang L; Dalovisio A; Pitel BA; Chen D; Oliveira JL; Wood AJ; Smadbeck JB; Johnson SH; Vasmatzis G; Haferlach C; Greipp PT; Hoppman NL; Ketterling RP; Baughn LB; Peterson JF
Cancer Genet; 2020 Feb; 241():67-71. PubMed ID: 31902694
[TBL] [Abstract] [Full Text] [Related]
13. evi1 triggers metabolic reprogramming associated with leukemogenesis and increases sensitivity to L-asparaginase.
Saito Y; Sawa D; Kinoshita M; Yamada A; Kamimura S; Suekane A; Ogoh H; Matsuo H; Adachi S; Taga T; Tomizawa D; Osato M; Soga T; Morishita K; Moritake H
Haematologica; 2020 Aug; 105(8):2118-2129. PubMed ID: 31649131
[TBL] [Abstract] [Full Text] [Related]
14. Measurable residual disease at myeloablative allogeneic transplantation in adults with acute lymphoblastic leukemia: a retrospective registry study on 2780 patients from the acute leukemia working party of the EBMT.
Pavlů J; Labopin M; Niittyvuopio R; Socié G; Yakoub-Agha I; Wu D; Remenyi P; Passweg J; Beelen DW; Aljurf M; Kröger N; Labussière-Wallet H; Perić Z; Giebel S; Nagler A; Mohty M
J Hematol Oncol; 2019 Oct; 12(1):108. PubMed ID: 31647022
[TBL] [Abstract] [Full Text] [Related]
15. evi1 induces autophagy to promote drug resistance via regulation of ATG7 expression in leukemia cells.
Niu Y; Yang X; Chen Y; Jin X; Li L; Guo Y; Li X; Xie Y; Zhang Y; Wang H
Carcinogenesis; 2020 Jul; 41(7):961-971. PubMed ID: 31593983
[TBL] [Abstract] [Full Text] [Related]
16. A critical role of epigenetic inactivation of miR-9 in evi1
Mittal N; Li L; Sheng Y; Hu C; Li F; Zhu T; Qiao X; Qian Z
Mol Cancer; 2019 Feb; 18(1):30. PubMed ID: 30813931
[TBL] [Abstract] [Full Text] [Related]
17. Radiation tolerance of the optic pathway in patients treated with proton and photon radiotherapy.
Li PC; Liebsch NJ; Niemierko A; Giantsoudi D; Lessell S; Fullerton BC; Adams J; Shih HA
Radiother Oncol; 2019 Feb; 131():112-119. PubMed ID: 30773177
[TBL] [Abstract] [Full Text] [Related]
18. Molecular and pathologic characterization of AML with double Inv(3)(q21q26.2).
Hodge JC; Bosler D; Rubinstein L; Sadri N; Shetty S
Cancer Genet; 2019 Jan; 230():28-36. PubMed ID: 30503564
[TBL] [Abstract] [Full Text] [Related]
19. Phosphaturic mesenchymal tumor with an admixture of epithelial and mesenchymal elements in the jaws: clinicopathological and immunohistochemical analysis of 22 cases with literature review.
Wu H; Bui MM; Zhou L; Li D; Zhang H; Zhong D
Mod Pathol; 2019 Feb; 32(2):189-204. PubMed ID: 30206408
[TBL] [Abstract] [Full Text] [Related]
20. Consistent Amplification of FRS2 and MDM2 in Low-grade Osteosarcoma: A Genetic Study of 22 Cases With Clinicopathologic Analysis.
He X; Pang Z; Zhang X; Lan T; Chen H; Chen M; Yang H; Huang J; Chen Y; Zhang Z; Jing W; Peng R; Zhang H
Am J Surg Pathol; 2018 Sep; 42(9):1143-1155. PubMed ID: 30001240
[TBL] [Abstract] [Full Text] [Related]
[Next]
